Xintong Medical-B (02160.HK) issued an announcement. On April 8, 2024, the company decided to grant share options to eligible participants in accordance with the share plan adopted by the company on June 27, 2023 to subscribe for up to 14.3238 million shares of the company's common shares with a face value of 0.000005 US dollars per share. However, this can only be realized after acceptance by the grantor. The exercise price for which the share options were granted was HK$1.002 per share.
心通医疗-B(02160.HK)授出合共1432.38万份购股权
Xintong Medical-B (02160.HK) granted a total of 14.3238 million share options
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.